Two Sigma Investments, LP Annovis Bio, Inc. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 166,219 shares of ANVS stock, worth $246,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,219
Previous 10,923
1421.73%
Holding current value
$246,004
Previous $54,000
361.11%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANVS
# of Institutions
53Shares Held
2.08MCall Options Held
88.1KPut Options Held
188K-
Vanguard Group Inc Valley Forge, PA648KShares$958,9210.0% of portfolio
-
Ubs Group Ag161KShares$238,0960.0% of portfolio
-
Geode Capital Management, LLC Boston, MA153KShares$225,8670.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA128KShares$189,0030.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$149,0490.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $12.1M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...